On December 21, 2022 Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, reported that the company will present at the 6th Annual Neuroscience Forum and the Biotech Showcase (Press release, Enveric Biosciences, DEC 21, 2022, View Source [SID1234625485]). Both events will be held live and are scheduled to coincide with the 41st Annual J.P. Morgan Health Care Conference in San Francisco, January 9-12, 2023.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details of the presentations are as follows:
Event:
6th Annual Neuroscience Innovation Forum
Date/Time:
January 8, 2023 at 1:30 PM PT
Location:
Marines Memorial Club, San Francisco, CA – Track D, Room Heritage
Website:
Event:
Biotech Showcase
Date/Time:
January 10, 2023 at 10:00 AM PT
Location:
Hilton Union Square, San Francisco, CA – Yosemite A
Website:
https://informaconnect.com/biotech-showcase/
During both presentations, Dr. Joseph Tucker, CEO of Enveric Biosciences will highlight Enveric’s experienced management team, recent corporate achievements, and the company’s robust pipeline of development programs targeting unmet needs in anxiety, depression and/or addiction disorders.
Throughout the week, members of the Enveric management team will participate in one-on-one meetings at the Hotel Fusion on 140 Ellis Street. To request a meeting, please email [email protected].